Literature DB >> 23206234

Immunohistochemical characterization and functional identification of mammary gland telocytes in the self-assembly of reconstituted breast cancer tissue in vitro.

Yongchao Mou1, Yan Wang, Junjie Li, Shuanghong Lü, Cuimi Duan, Zhiyan Du, Guili Yang, Weizhen Chen, Siyang Zhao, Jin Zhou, Changyong Wang.   

Abstract

Telocyte (TC) as a special stromal cell exists in mammary gland and might play an important role in the balance of epithelium-stroma of mammary gland. Considering that different types of breast interstitial cells influence the development and progression of breast cancer, TCs may have its distinct role in this process. We here studied the roles of TCs in the self-assembly of reconstituted breast cancer tissue. We co-cultured primary isolated TCs and other breast stromal cells with breast cancer EMT-6 cells in collagen/Matrigel scaffolds to reconstitute breast cancer tissue in vitro. Using histology methods, we investigated the immunohistochemical characteristics and potential functions of TCs in reconstituted breast cancer tissue. TCs in primary mammary gland stromal cells with long and thin overlapping cytoplasmic processes, expressed c-kit/CD117, CD34 and vimentin in reconstitute breast cancer tissue. The transmission electron microscopy showed that the telocyte-like cells closely communicated with breast cancer cells as well as other stromal cells, and might serve as a bridge that directly linked the adjacent cells through membrane-to-membrane contact. Compared with cancer tissue sheets of EMT-6 alone, PCNA proliferation index analysis and TUNEL assay showed that TCs and other breast stromal cells facilitated the formation of typical nest structure, promoted the proliferation of breast cancer cells, and inhibited their apoptosis. In conclusion, we successfully reconstituted breast cancer tissue in vitro, and it seems to be attractive that TCs had potential functions in self-assembly of EMT-6/stromal cells reconstituted breast cancer tissue.
© 2012 The Authors. Published by Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23206234      PMCID: PMC3823137          DOI: 10.1111/j.1582-4934.2012.01646.x

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


Introduction

Mammary gland telocytes (TCs) were identified as special populations in stromal cells in mammary gland by Popescu and his co-workers [1, 2]. During the last few years, the presence of TCs has been documented in different organs and tissues, such as mammary gland [3, 4], epicardium [5], myocardium [6], endocardium [7], lungs and pulmonary veins [8, 9], male genital organs [10], uterus as well as fallopian tube [11], placenta [12], gallbladder [13], oesophagus [14], pancreas [15], meninges, choroid plexus [16] and skin [17]. TCs shared 2–3 long (20–80 μm), thin, moniliform prolongations suddenly emerging from a small, and oval cell body [1]. Researchers proposed that TCs might have functions in the intercellular communication and pace making [1, 18]. In experimental acute myocardial infarction, TCs were demonstrated to be in close spatial relationships with endothelial tubes through direct physical interaction or indirectly by paracrine secretion including VEGF and NOS2 within the ‘angiogenic zones’, which suggests the participation of TCs in neo-angiogenesis during the late stage of myocardial infarction [19]. Recently, Ardeleanu et al. studied the relationship between TCs and PEComas and GISTs. They propose TCs as the common cell origin of both PEComas and GISTs [20]. This suggests that the participation TCs might be associated with tumour genesis and biology. Breast cancer is a most common malignant disease for women, while the underlying etiological mechanisms have not been clarified [21]. In development and progression of breast cancer, stromal cells as an important component of stroma contribute to tumour microenvironment, fostering cancer cells. Orimo et al. demonstrated that fibroblasts can promote tumour growth and angiogenesis in invasive breast cancer [22]. It was shown that endothelial cells affect the oxygen-sensing pathways, which lead to inhibit the invasion and metastasis of cancer cells [23]. Adipocytes can secrete adipokines including leptin, ApN and HGF, which have angiogenic properties and promote invasion [24, 25]. The intercellular communications between breast cancer cells and stromal cells are essential for the structural assembly as well as malignant phenotype of breast cancer [26-28]. Until now, there has been no evidence showing that TCs participate the self-assembly of breast cancer. Traditionally, the most common approaches to explore the functions of stromal cells to breast cancer are through 2D cell culture, animal models or tissues originated from patient. However, 2D cell culture was confined by the shortage of three-dimensional (3D) tumour microenvironment in vivo. Animal models were limited by their sophisticated physiological conditions. Moreover, tissues from patient were confronted with the ethical problems. In recent years, the engineered breast cancer tissues in vitro reconstituted by different materials and different seeding cells have been used to study mechanisms of migration, metastasis and angiogenesis of breast cancer. Baker et al. studied the mutual effect among cell motility and 3D collagen properties including stiffness and architecture in progression of a mammary epithelial cell (MEC) cancer [29]. In Matrigel 3D culture system, researchers revealed that TGFβ regulated Par6 signalling directly to influence the metastasis of cancer cells [30]. Fischbach et al. found that IL-8 secretion was affected by integrin engagement and the angiogenic signal was regulated by tumour microenvironment through comparing the angiogenic properties in 2D and 3D alginate hydrogel [31]. Therefore, the tumour tissue reconstitution in vitro was an ideal tool for studying the behaviours of tumour cells under specific tumour microenvironment. Stromal cells as important components of tumour microenvironment have been studied via 3D culture. Fibroblasts can promote the invasion of tumour cells in 3D Matrigel through upregulating MMP-2 activity and metastasis promoting S100A4 protein [32], and potentiating cancer cells proliferation in Matrigel co-culture system [33]. Adipocytes, instead of preadipocytes, could enhance the growth of tumour cells in 3D collagen culture, and the expression of E-cadherin was not influenced by both adipocytes and preadipocytes [34]. Endothelial cells induced epithelial to mesenchymal transition (EMT) of breast cancer cells through manipulating the expression of E-cadhein to N-cadherin, and promoted the capability of migration, especially making cancer cells acquire cancer stem-cell character [35]. Although there were many studies reported on the function of different kinds of stromal cells to breast cancer, the relationship of specific interstitial cell, TCs with breast cancer has not been investigated. In this work, we aimed to characterize TCs in EMT-6/stromal cells reconstituted breast cancer tissue, to try to assess their potential function in self-assembly of reconstituted breast cancer tissue in vitro. This study would provide evidence of TCs for influencing the typical nest structure assembly in breast cancer and the biological properties of cancer cells.

Materials and methods

Chemicals and cell culture reagents

HEPES was purchased from Sigma-Aldrich (St. Louis, MO, USA). DMEM, RMPI Medium 1640 and DMEM/F12 were purchased from Gibco/Invitrogen (Life Technologies Corporation, NY, USA). Foetal bovine serum (FBS) was purchased from Sigma-Aldrich. Matrigel™ and rat tail type I collagen were purchased from BD Biosciences (Franklin Lakes, NJ, USA). Methylene blue solution was purchased from Merck (Merck KGaA, Darmstadt, Germany). Phalloidin-FITC was purchased from Sigma-Aldrich.

Cell maintenance

The breast cancer cell line EMT-6 was derived from a BALB/c mouse after implantation of a hyperplastic mammary alveolar nodule, and it was purchased from the American type culture collection (Rockville, MD, USA). EMT-6 was cultured in RMPI medium 1640 (Sigma Chemical, St. Louis, MO, USA) containing 10% FBS (Sigma Chemical). Primary isolated stromal cells were cultured in the medium of DEMEM/F12 (Gibco) containing 10% FBS. Reconstituted breast cancer tissues, by mixing EMT-6 with stromal cells, were cultured in the medium of DMEM/F12 supplemented by 10% FBS. All cultures were incubated at 37°C in humid conditions containing 5% CO2.

Primary culture and identification of TCs in 2D mammary gland stromal cells culture

Isolated normal mammary gland derived stromal cells referring to Allinen et al. [36] with some modifications changing four cell strainers including 500 μ, 250 μ, 100 μ and 40 μ to two sieve of 250 μ and 40 μ. In brief, collected normal mammary gland from mid-pregnant BALB/c mice was minced to small fragments, digested with collagenase I (100 U/ml)/hyaluronidase (150 U/ml), diluted in DMEM/F12 medium without FBS, incubated in a mixture of tissue and digestion solutions at 37°C, then filtered through sieve mesh of different sizes, after centrifugation and suspended precipitation and was cultured in DMEM/F12 containing 10% FBS. We then characterized stromal cells through expression of vimentin, α-SMA, CK14, CK18 and Desmin [37]. To identify TCs, the primary culture cells were observed by phase contrast microscope.

Supravital methylene blue staining

The supravital methylene staining according to the method mentioned in published papers [1, 6, 38] was used to identify TCs in primary mammary gland interstitial cells. In brief, phenol red-free DMEM was pre-warmed to wash cells culture, which was then incubated in 0.02% methylene blue solution at 37°C for 20 min. We quickly washed cells with phenol red-free DMEM medium, and observed results under Olympus microscope and acquired pictures as quickly as possible to avoid contamination.

Mitochondria-specific labelling

TMRM (Immunochemistry Technologies, Bloomington, MN, USA) was used to label mitochondria specifically. Cells grown on cover slips were removed from culture dish and incubated in TMRM dissolved in PBS at 37°C for 15 min., then washed with PBS and label nucleus with Hoechst 33258. The results were observed with Zeiss confocal microscope (Zeiss 510 META; Zeiss, Oberkochen, Germany).

Reconstituted 3D breast cancer tissue in vitro

Breast cancer tissues in vitro were reconstituted by mixing EMT-6 and normal mammary gland interstitial cells after three passages (1:1) with collagen I/Matrigel mixture as previously described [39]. In brief, 0.5 ml of concentrated 2X H-DMEM medium containing 10% FBS was mixed with 0.5 ml rat tail collagen and Matrigel in 4:1 (v/v),and then the mixture was neutralized quickly by 0.1 mol/l NaOH at low temperature, mixing 1.0 × 106 EMT-6 and 1.0 × 106 interstitial cells with scaffold and mixture was pipetted into casting moulds for incubation at 37°C. one millilitre DMEM/F12 containing 10% FBS was seeded to the dish after 60 min. of incubation, and the culture medium was changed daily. Cancer tissue sheet of EMT-6 alone was reconstituted following the same procedures with the number of 1 × 106 as control group.

Histology and immunohistological staining

Samples obtained at 3, 5, and 7 days were fixed in 4% formaldehyde and embedded in paraffin. Sections of 3 μm thickness were cut for haematoxylin and eosin staining as regular procedures. For immunohistochemistry, the primary antibodies used were: α-smooth muscle actin (diluted 1:800; Sigma-Aldrich), vimentin (diluted 1:800; Santa Cruz Biotechnology, Inc., CA, USA), c-kit/CD117 (diluted 1:200), E-cadherin (Abcam clone decma-1, dilution 1:800), collagen IV (diluted 1:200), pan-CK (diluted 1:200), PCNA (diluted 1:200). Sections were incubated with primary antibodies overnight at 4°C. Then, biotin-labelled secondary antibodies were used and finally detected with diaminbenzidine (Sigma-Aldrich). Nuclei were stained by haematoxylin. The number of PCNA-positive nuclei was estimated in 1000 randomly scored cells of each reconstituted tissue sheets and expressed in per cent as PCNA index.

Immunofluorescence and confocal microscopy

For immunofluorescence, the primary antibodies were CD34 (diluted 1:100), CK14 (Santa Cruz Biotechnology, Inc., diluted 1:200), CK18 (diluted 1:100), Desmin (diluted 1:200), c-kit/CD117 (diluted 1:200), vimentin (diluted 1:800) and pan-CK (diluted 1:200). Sections of samples were incubated with primary antibodies overnight at 4°C, then were incubated with FITC-labelled goat anti-mouse IgG or FITC-labelled rabbit anti-rat IgG, Cy3-labelled goat anti-mouse IgG or Cy3-labelled goat anti-rabbit IgG as the secondary antibodies. Hoechst 33258 was used to stain the nucleus. The results were observed under a Zeiss confocal microscope (Zeiss 510 META; Zeiss, Oberkochen, Germany) with BioRad confocal software (Bio-Rad Laboratories, Inc., CA, USA). The expression of F-actin was detected by Phalloidin-FITC, and procedures used were the following: sections were deparaffinized and permeabilized with 0.1% Triton X-100 in PBS, then stained with 50 mg/ml fluorescent phalloidin conjugate solution in PBS (containing 1% DMSO from the original stock solution) for 40 min. at room temperature.

Transmission electron microscopy (TEM)

The EMT-6/stromal cells reconstituted breast cancer tissue samples were fixed in 2.5% glutaraldehyde containing 0.1 mol/l sodium cacodylate buffer (pH 7.4) for 6 hrs, postfixed in 1% phosphate-buffered OsO4 (pH 7.4) and embedded in epoxy resin. Toluidine blue in 0.1 M borate buffer was used to stain semi-thin section. The sections were observed under a light microscope and cut ultra-thin sections were examined by TEM (Technai10; Philip, Eindhoven, Netherlands).

TUNNEL Assays

Apoptosis was examined following the manual of MEBSTAIN Apoptosis kit II (MBL MED. &BIO. Co., Nagoya, Japan). In brief, sections were incubated with proteinase K solution for 30 min. at 37°C. TdT solution was pipetted to label DNA nick end of samples, and then Avidin-FITC II solution was used to preceed histochemistry which was followed by counterstaining with Propidium Iodide. Finally, the positive stained cells were observed and counted under microscopy. We randomly took five pictures per section under 20× fields and repeated the same procedure three times at least.

Statistical analysis

At least three independent experiments were assessed. Data were evaluated for significance through Student t tests; ANOVA was used to compare the data of cells going through apoptosis. Data were considered statistically significant at P < 0.05.

Results

Identification of TCs in primary cultured cells derived from normal mammary gland

In 2D primary cultured mammary gland interstitial cells, we observed cells with suggestive morphology for TCs by phase contrast microscopy. These cells have long, slender prolongations extended from fusiform (Fig. 1A), polygonal (Fig. 1B) or triangular (Fig. 1C) cell body. The long and thin moniliform prolongations (Telopodes-Tps) suddenly emerge from the spindle cell body as is shown in Figure 1A. They are an alternation of thin segments-podomers-and dilated segments-podoms. TCs with polygonal cell body (indicated by arrows) shared at least four telopodes connecting with surrounding stromal cells (Fig. 1B). The numbers of the beads along the string of prolongations within TCs were quite different. A typical Tp is presented in Figure 1C having at least eight podoms (indicated by arrows).
Fig. 1

Telocytes in 2D breast stromal cells: phase contrast microscopy, supravital methylene blue staining and mitochondria-specific staining. (A) Fusiform TCs with long processes (indicated by arrow). (B) Polygonal TCs with four long, thin prolongations (indicated by arrows). (C) Triangular TCs with bead-like telopodes, eight dilations in telopodes were visible (indicated by arrows). (D) and (E) Supravital methylene blue staining of TCs. An octopus-like telocyte with five bead-like telopodes (indicated by arrows) in D. TCs connected with surrounding cells to form a network by their telopodes with bead-like conformation in E. (F) and (G) Mitochondria immunolabelled with TMRM of TCs. The strong prolongation with dilations of telocyte could be observed in primary breast stroma cell culture. The prolongations were indicated by arrows.

Telocytes in 2D breast stromal cells: phase contrast microscopy, supravital methylene blue staining and mitochondria-specific staining. (A) Fusiform TCs with long processes (indicated by arrow). (B) Polygonal TCs with four long, thin prolongations (indicated by arrows). (C) Triangular TCs with bead-like telopodes, eight dilations in telopodes were visible (indicated by arrows). (D) and (E) Supravital methylene blue staining of TCs. An octopus-like telocyte with five bead-like telopodes (indicated by arrows) in D. TCs connected with surrounding cells to form a network by their telopodes with bead-like conformation in E. (F) and (G) Mitochondria immunolabelled with TMRM of TCs. The strong prolongation with dilations of telocyte could be observed in primary breast stroma cell culture. The prolongations were indicated by arrows. The existence of TCs in 2D breast stromal cells monolayer culture was further confirmed by supravital methylene blue staining. An ‘octopus-like’ TC with at least five Tps could be observed in cell culture monolayer, clearly stained by methylene blue dye (Fig. 1D). TCs could form networks as it is shown in Figure 1E, the intricate interstitial networks could be constructed by telopodes and the cell body of TCs showed elongated appearance. Other vital staining, mitochondria-specific labelling with TMRM showed that TCs shared long and moniliform processes with dilations containing mitochondria (indicated by arrows; Fig. 1F and G). The common markers of TCs including c-kit/CD117 (Fig. 2A), vimentin (Fig. 2B) and CD34 (Fig. 2C) were detected in primary culture cells. In all the detected markers, podiums could be observed. These markers are mainly expressed within cytoplasm, including Tps, but with a discrete expression pattern. These results also confirmed the existence of TCs in 2D monolayer culture of breast stromal cells.
Fig. 2

Immunofluorescence and immunohistochemistry of TCs and identification of mammary gland stromal cells in 2D culture. The central inset indicated stromal cells derived from breast tissue with different morphology of cells observed under phase contrast microscope. (A) Fluorescence microscopic observation showed c-kit/CD117-positive cells with obviously telopodes (green), and dilations were pointed by arrows. (B) Immunofluorescent staining result of vimentin-positive TCs with long prolongation (green, indicated by arrows). (C) Immunohistochemical staining result of CD34-positive TCs with telopodes. The dilations were indicated by arrows. (D–H) Immunofluorescent staining for other stromal cells in 2D monolayer cell culture. (D) vimentin-positive cells, (E) α-SMA-positive cells, (F) CK18-negative cells, (G) CK 14-negative cells, (H) Desmin-negative cells.

Immunofluorescence and immunohistochemistry of TCs and identification of mammary gland stromal cells in 2D culture. The central inset indicated stromal cells derived from breast tissue with different morphology of cells observed under phase contrast microscope. (A) Fluorescence microscopic observation showed c-kit/CD117-positive cells with obviously telopodes (green), and dilations were pointed by arrows. (B) Immunofluorescent staining result of vimentin-positive TCs with long prolongation (green, indicated by arrows). (C) Immunohistochemical staining result of CD34-positive TCs with telopodes. The dilations were indicated by arrows. (D–H) Immunofluorescent staining for other stromal cells in 2D monolayer cell culture. (D) vimentin-positive cells, (E) α-SMA-positive cells, (F) CK18-negative cells, (G) CK 14-negative cells, (H) Desmin-negative cells. Meanwhile, we excluded the populations of epithelial cells in 2D monolayer cell culture by detecting the expression of stromal cells markers. The results showed that the cells were vimentin+ and α-SMA+ (Fig. 2D and E), and we could not detect or rarely detected the expression of CK18, CK14 and Desmin in cells, indicating that there were no epithelial cells in the stromal cells population (Fig. 2F–H). The stromal cells could be used to reconstitute breast cancer tissues in vitro.

Immunohistochemical characterization of TCs and distribution of EMT-6 cells in EMT-6/stromal cells reconstituted breast cancer tissue in vitro

We constructed breast cancer tissues by combining EMT-6 with normal stromal cells derived from breast tissue in vitro by using collagen I/Matrigel scaffolds. Reconstituted breast cancer tissue constructed by EMT-6 alone was used as control. Cells mixed with collagen I/Matrigel scaffold contracted at day 1 after cultivation, and most of cells self-assembly to typical nest structure due to the static strength of glass tube (Fig. 3A–D). The black arrowheads indicated the nest structure formed in the reconstituted breast cancer tissue. During the culture, the morphological differences between the tissue sheets of EMT-6 alone and EMT-6/stromal reconstituted breast cancer tissue can be obviously observed under light microscope (Fig. 3A and C). In tissue sheets of EMT-6 cells alone, cells presented more aggregated alignment compressing to each other (Fig. 3A). Cells in the sheets of EMT-6/stromal cells reconstituted breast cancer tissue exhibited a spread-out appearance and well distributed well within the whole tissue (Fig. 3C). The differences of these two kinds of cancer tissue sheets could be compared by using haematoxylin and eosin staining. It can be observed obviously that some nest structures (indicated by black arrowhead) formed in these sheets, especially some cord-like structures (indicated by white arrowhead) in EMT-6/stromal cells reconstituted breast cancer tissue (Fig. 3D). In cancer tissue sheets of EMT-6 alone, the nest structures seemed more condensed and located mainly in the tissue edge (Fig. 3B). In contrast to this morphology, the nest structures exhibited a more homogenous appearance distributed in the whole EMT-6/stromal cells tissue sheets. Stromal cells dispersed separately and were often located around breast cancer cells (indicated by black arrow) (Fig. 3D).
Fig. 3

Comparison of self-assembly breast cancer structures between two groups of reconstituted breast cancer tissue sheets. (A) EMT-6 alone reconstituted breast cancer tissues were observed by phase contrast microscopy. (B) H&E staining of EMT-6 alone reconstituted breast cancer tissue at the seventh day of culture. Black arrowhead indicates nest structures. (C) EMT-6/stromal cells reconstituted breast cancer tissues were observed by phase contrast microscopy. (D) H&E staining of EMT-6/stromal cells reconstituted breast cancer tissue at the seventh day of culture. Black arrowhead indicates nest structures and white arrowhead indicates cord-like structures. Black arrow indicates stromal cells.

Comparison of self-assembly breast cancer structures between two groups of reconstituted breast cancer tissue sheets. (A) EMT-6 alone reconstituted breast cancer tissues were observed by phase contrast microscopy. (B) H&E staining of EMT-6 alone reconstituted breast cancer tissue at the seventh day of culture. Black arrowhead indicates nest structures. (C) EMT-6/stromal cells reconstituted breast cancer tissues were observed by phase contrast microscopy. (D) H&E staining of EMT-6/stromal cells reconstituted breast cancer tissue at the seventh day of culture. Black arrowhead indicates nest structures and white arrowhead indicates cord-like structures. Black arrow indicates stromal cells. We then determined the distribution of EMT-6 by using immunohistochemistry of epithelia specific marker, pan-CK in EMT-6/stromal cells reconstituted breast cancer tissue (Fig. 4A and B). EMT-6 cells clustered and self-assembled to nest structures. pan-CK-positive EMT-6 (arrow in Fig. 4B) cells distributed in the whole breast cancer tissues sheets. Stromal cells (arrowhead in Fig. 4B) distributed adjacent to EMT-6 cells, suggesting the complexity of cell types in these models, which mimic the cellular composition of breast cancer tissue in vivo.
Fig. 4

Immunohistochemical staining of pan-CK was detected in EMT-6/stromal cells reconstituted breast cancer. (A) pan-CK-positive EMT-6 cells dispersed in whole reconstituted breast cancer. (B) Higher magnification of the nest structures. EMT-6 (indicated by arrows) presented in reconstituted breast cancer tissue, and the stromal cells (indicated by arrowhead) accompanied by EMT-6 cells.

Immunohistochemical staining of pan-CK was detected in EMT-6/stromal cells reconstituted breast cancer. (A) pan-CK-positive EMT-6 cells dispersed in whole reconstituted breast cancer. (B) Higher magnification of the nest structures. EMT-6 (indicated by arrows) presented in reconstituted breast cancer tissue, and the stromal cells (indicated by arrowhead) accompanied by EMT-6 cells. TCs in EMT-6/stromal cells reconstituted breast cancer tissue were paid more attention. Although there are no specific markers only for TCs, c-kit/CD117, CD34 and vimentin can be used in combination to identify them. We performed immunohistochemistry and immunofluorescence staining to determine vimentin+, c-kit/CD117+ and CD34+ TCs in EMT-6/stromal cells reconstituted breast cancer tissue (Fig. 5). The arrows indicated that TCs with distinctive thin prolongations could accompany other cells, and vimentin was mainly located along the process of cells (Fig. 5A and B). In addition, we found that EMT6 breast cancer cells were c-kit/CD117-positive (Fig. 5C and D), which confirmed the observations reported by other group [40], but the distinct morphology made TCs clearly distinguished from other periphery breast cancer cells within reconstituted tumour tissue. Moreover, the immunofluorescent staining exhibited the expression of vimentin (Fig. 5E), c-kit/CD117 (Fig. 5F) and CD34 (Fig. 5G and H) in typical TCs, which distributed intermittently instead of continuously in the whole cell body.
Fig. 5

Immunohistochemical and immunofluorescent morphology of TCs in EMT-6/stromal cells reconstituted breast cancer tissue. (A–D) Immunohistochemical staining of TCs. (A) and (B) TCs were positive for vimentin with clear telopodes with dilations in A and with long prolongations in B (indicated by arrows, respectively). (C) and (D) TCs were positive for c-kit/CD117. (E–H) Immunofluorescent staining of TCs. The arrows indicate TCs. (E) Vimentin-positive TCs detected by immunofluorescence. (F) c-kit/CD117-positive TCs detected by immunofluorescence. (G) and (H) CD34-positive TCs detected by immunofluorescence.

Immunohistochemical and immunofluorescent morphology of TCs in EMT-6/stromal cells reconstituted breast cancer tissue. (A–D) Immunohistochemical staining of TCs. (A) and (B) TCs were positive for vimentin with clear telopodes with dilations in A and with long prolongations in B (indicated by arrows, respectively). (C) and (D) TCs were positive for c-kit/CD117. (E–H) Immunofluorescent staining of TCs. The arrows indicate TCs. (E) Vimentin-positive TCs detected by immunofluorescence. (F) c-kit/CD117-positive TCs detected by immunofluorescence. (G) and (H) CD34-positive TCs detected by immunofluorescence.

Spatial location of TCs and EMT-6 cells in EMT-6/stromal cells reconstituted breast cancer tissue

To investigate the potential roles of TCs in the organization of breast cancer tissues in vitro, we applied c-kit/CD117 and pan-CK double immunofluorescent staining to examine the spatial intercellular relationship between TCs and EMT-6 breast cancer cells in reconstituted tissue sheets. In Figure 6A and B, red fluorescence-stained pan-CK+ breast cancer cells self-assembled into nest structures, and green fluorescence-stained c-kit/CD117+ TCs were closely located around the cancer cells. Although some EMT6 cancer cells were with faint c-kit/CD117 staining, the pronounced green fluorescence and typical morphology of TCs could be identified in reconstituted cancer tissue sheets. The intercellular interaction between TCs and other cells exhibited different appearance. In Figure 6A and D, c-kit/CD117+ cells (indicated by white arrow) invaded into the clustered cell nest and contacted the proximal cancer cells (indicated by white arrowhead). Additionally, c-kit/CD117+ cells were situated at the niche of nest across the adjacent cancer cell clusters (Fig. 6B and E). The typical telopode features of c-kit/CD117+ TCs could be observed clearly in Figure 6C and F. The long process of TCs (indicated by white arrow) spread on the surface of the intercellular interaction area and was overlaid with the bottom dark red-stained pan-CK+ cytosol of breast cancer cells (indicated by white arrowhead). These results revealed that TCs could accompany, contact and link with EMT-6 cancer cells, which seemed to be participating in the self-assembly of nest structures of reconstituted breast cancer tissue.
Fig. 6

The spatial relationship between TCs and EMT-6 cells in EMT-6/stromal cells reconstituted breast cancer tissue was observed by double immunofluorescence staining. (A–C) c-kit/CD117+ cells was labelled with green colour and pan-CK+ cells was labelled with red colour. The nuclei were stained by Hoechst 33258. (D–F) Higher magnification of A, B and C. c-kit/CD117+ TCs distributed in the reconstituted breast cancer tissues (indicated by arrows), which are located close to pan-CK+ EMT-6 cells nest structure. EMT-6 cells were red stained and are indicated by arrowheads.

The spatial relationship between TCs and EMT-6 cells in EMT-6/stromal cells reconstituted breast cancer tissue was observed by double immunofluorescence staining. (A–C) c-kit/CD117+ cells was labelled with green colour and pan-CK+ cells was labelled with red colour. The nuclei were stained by Hoechst 33258. (D–F) Higher magnification of A, B and C. c-kit/CD117+ TCs distributed in the reconstituted breast cancer tissues (indicated by arrows), which are located close to pan-CK+ EMT-6 cells nest structure. EMT-6 cells were red stained and are indicated by arrowheads. The TEM observation of EMT-6/stromal cells reconstituted breast cancer tissue sections showed that the cells (indicated by white arrow), which resembled the appearance of TCs with thin and long process extend along the intercellular space of EMT6 breast cancer cells and interstitial cells (Fig. 7A–D). The telocyte-like cells interacted with breast cancer cells and other stromal cells through membrane-to-membrane contact (indicated by white arrow head). In Figure 7B, it could be observed clearly that a telocyte-like cell exhibited a very long and tortuous telopodes with five corner protuberances communicating with adjacent cells (indicated by white arrow head). It also could be found to be embedded into a cluster of cells, which in close contact with the surrounding cells. Figure 7C showed a cross-section of a telocyte-like cell. It was located among three cells and might serve as a bridge that directly linked the adjacent cells with membrane-to-membrane contact. This kind of typical transcellular interaction could also be observed in Figure 7D and E. These bridging structures further suggested the potential roles of telocyte-like cells in the self-assembly of reconstituted breast cancer tissue.
Fig. 7

The transmission electron microscopy showed the interaction between telocyte-like cells and adjacent cells in EMT-6/stromal cells reconstituted breast cancer tissue. (A–D) The long and thin telopodes of telocyte-like cells (white arrow) exhibited distinct contact points (white arrow head) with the membrane of other cells. (E) Higher magnification of (D).

The transmission electron microscopy showed the interaction between telocyte-like cells and adjacent cells in EMT-6/stromal cells reconstituted breast cancer tissue. (A–D) The long and thin telopodes of telocyte-like cells (white arrow) exhibited distinct contact points (white arrow head) with the membrane of other cells. (E) Higher magnification of (D).

Potential function of TCs in self-assembly of EMT-6/stromal cells reconstituted breast cancer tissue

The different morphology between EMT-6/stromal cells and EMT-6 alone reconstituted breast cancer tissue, which has been described above, provided clues that the supplement of primary stromal cells containing TCs might have potential effects on the biological phenotypes of reconstituted breast cancer tissue. We subsequently compared the ability of cell proliferation and resistance to apoptosis of cancer cells in two tissue groups. As proliferation rate is an important factor determining the tumour aggressiveness, the evaluation of PCNA index (the percentage of PCNA- immunopositive nuclei in the investigated tissue sample) is suggested as useful in evaluating the malignancy of breast cancer. We then compared the percentage of PCNA-positive cells after 3 and 7 days culture in these two reconstituted breast cancer tissues (Fig. 8A and B). The proliferation index of cells in the EMT-6/stromal cells reconstituted tissue sheets in the 3 days' culture with the mean of 42.4%, which contrasts with 37.2% in tissue sheets of EMT-6 alone. After 7 days' culturing, the proliferation index in EMT-6/stromal cells tissue sheets reached 62.8% versus 50.53% in tissue sheets of EMT-6 alone (Fig. 8C). A higher proliferation index was acquired in EMT-6/stromal cells reconstituted breast cancer tissue than in the tissue sheets of EMT-6 alone. This result suggested that TCs and other stromal cells might improve cancer cell growth to some degree.
Fig. 8

Comparison of the proliferation index by detecting the percentage of PCNA-positive cells in two groups of reconstituted breast cancer tissue. Immunohistochemical analysis of the expression of PCNA was evaluated in EMT-6 alone (A) and EMT-6/stromal cells reconstituted breast cancer tissue (B). Quantification of the proliferation index of PCNA-positive cells in EMT-6/stromal cells and EMT-6 alone reconstituted breast cancer tissue is shown in (C). Bars show the standard error of the mean.

Comparison of the proliferation index by detecting the percentage of PCNA-positive cells in two groups of reconstituted breast cancer tissue. Immunohistochemical analysis of the expression of PCNA was evaluated in EMT-6 alone (A) and EMT-6/stromal cells reconstituted breast cancer tissue (B). Quantification of the proliferation index of PCNA-positive cells in EMT-6/stromal cells and EMT-6 alone reconstituted breast cancer tissue is shown in (C). Bars show the standard error of the mean. The characteristic features of breast cancer are the property of deregulated proliferation and acquired ability of resistance to apoptosis. Through quantitative comparison of the apoptotic rate between the two groups of reconstituted breast cancer tissue by using TUNEL assay, we found that the percentage of cells going through apoptosis in tissue sheets of EMT-6 alone was greater than that of cells in EMT-6/stromal cells reconstituted breast cancer tissue (Fig. 9). In other words, TCs and other stromal cells obviously attenuated apoptosis and prompted survival of EMT-6 breast cancer cells. The supplement of stromal cells containing TCs in EMT-6/stromal cells reconstituted breast cancer tissue could not only affect the self-assembly of cancer tissues but also influence the proliferation and apoptosis of breast cancer cells.
Fig. 9

Apoptosis was detected by using TUNEL assay. Apoptosis index was measured by TUNEL assay in EMT-6 alone (A) and EMT-6/stromal cells reconstituted breast cancer tissue (B). Quantification of the apoptosis index of cells in EMT-6/stromal cells and EMT-6 alone reconstituted breast cancer tissues is shown in (C). At least three independent experiments were assessed. Bars show the standard error of the mean. Data were evaluated for significance through Student t tests; ANOVA was used to compare the data of cells going through apoptosis. Data were considered statistically significant at P < 0.05, which is indicated as *.

Apoptosis was detected by using TUNEL assay. Apoptosis index was measured by TUNEL assay in EMT-6 alone (A) and EMT-6/stromal cells reconstituted breast cancer tissue (B). Quantification of the apoptosis index of cells in EMT-6/stromal cells and EMT-6 alone reconstituted breast cancer tissues is shown in (C). At least three independent experiments were assessed. Bars show the standard error of the mean. Data were evaluated for significance through Student t tests; ANOVA was used to compare the data of cells going through apoptosis. Data were considered statistically significant at P < 0.05, which is indicated as *. In addition, we evaluated the effect of stromal cells containing TCs on the organization of extracellular matrix, cell–cell junction and cytoskeleton assembly by comparison of the expression of collagen IV, E-cadherin and F-actin between these two groups of reconstituted breast cancer tissue. The presence of collagen IV in EMT-6 alone and EMT-6/stromal cells cancer tissue sheets indicated the formation of basement membrane (Fig. 10A and B). All typical nest structure formed in both of them can express a marker of cell–cell junction, E-cadherin (Fig. 10C and D). These results revealed that cancer cells embedded in collagen I/Matrigel could secrete components of basement membrane that resemble the behaviour of cancer cells in vivo. Through detection of F-actin microfilament by FITC-phalloidine, we found that F-actin is mainly located in the cytoplasm and the filaments seemed prominent at the interface of cell–cell contacts (Fig. 10E and F). The F-actin filament in tissue sheets of EMT-6 cells alone exhibited very short and slim filament without pronounced actin bundles (Fig. 10E). Contrast to that appearance, the F-actin filament in EMT-6/stromal cells reconstituted breast cancer tissue presented a well-assembled pattern with thick bundles, and aggregated along the boundary of intercellular contacted areas (Fig. 10F). As the F-actin filaments are the important component of cytoskeletons which closely relate to cell movements, the differences in F-actin assembly revealed the higher movement ability of cells in EMT-6/stromal cells reconstituted breast cancer tissue than those in the tissue sheets of EMT-6 cells alone.
Fig. 10

The expression of collagen IV, E-cadherin and F-actin in reconstituted breast cancer tissue was observed. (A) and (B) The expression of collagen IV was detected by immunohistochemistry in EMT-6 cells alone (A) and EMT-6/stromal cells (B) reconstituted breast cancer tissue respectively. (C) and (D) The expression of E-cadherin was detected by using immunohistochemistry in EMT-6 alone and EMT-6/stromal cells reconstituted breast cancer tissue, respectively. (E) and (F) Detection of F-actin by using immunofluorescence in EMT-6 alone and EMT-6/stromal cells reconstituted breast cancer tissue, respectively.

The expression of collagen IV, E-cadherin and F-actin in reconstituted breast cancer tissue was observed. (A) and (B) The expression of collagen IV was detected by immunohistochemistry in EMT-6 cells alone (A) and EMT-6/stromal cells (B) reconstituted breast cancer tissue respectively. (C) and (D) The expression of E-cadherin was detected by using immunohistochemistry in EMT-6 alone and EMT-6/stromal cells reconstituted breast cancer tissue, respectively. (E) and (F) Detection of F-actin by using immunofluorescence in EMT-6 alone and EMT-6/stromal cells reconstituted breast cancer tissue, respectively.

Discussion

This study provided evidence that stromal cells containing TCs might influence the self-assembly of reconstituted breast cancer tissue. In combination of the immunohistochemical analysis and the TEM observation, we could identify and characterize TCs in reconstituted breast cancer tissue and investigate their relationship with cancer cells in spatial locations. These results might provide clues for exploration of the potential functions of TCs in tissue organization in vitro. Breast cancer cells cultured in 3D scaffold materials could develop into tumour tissues [41]. There are some observations indicating that addition of stromal cells could potentiate the reconstitution of breast cancer in 3D culture systems than cultivating cancer cells alone [42]. Breast cancer cells possess the ability of self-assembly to form tissue-specific structures [43].These lines of evidence suggested that the incorporation of stromal cells of mammary gland has essential roles in improving the self-assembly formation of breast cancer tissue. TCs are the important components of stromal cells, which have revealed latent functions in other organs. In normal mammary gland, the balance of epithelium/stroma was supposed to be affected by TCs, which was considered a critical stromal component of the interstitial morpho-functional unit [6]. However, the roles of TCs in 3D reconstruction of breast cancer tissues are still under investigation. Therefore, it is of significant importance for the immunohistochemical characterization and functional identification of mammary gland TCs during the development of breast cancer tissues within scaffold biomaterials. There is also an urgent need to understand the specific features of TCs in engineered breast cancer tissues by applying immunohistological analysis, which may lay the foundation of further research on TCs. Through TEM, we observed the telocyte-like cells spreading along the cellular membrane of other adjacent cells and interacted with each other through membrane-to-membrane contact. However, there is a significant discrepancy between normal tissues in vivo and reconstituted tissues in vitro. Compared with cells in vivo or cultured under 2D conditions, cells in the materials exhibit a significant variation of biological features, which contribute to the discrepancy of ultrastructure. We suppose that the change in living microenvironment of TCs might contribute to their characteristic variance observed under TEM. Moreover, the physical-chemical property and other features of biomaterial will influence the cellular morphology of transplanted cells. Therefore, it is of great importance to put forward the investigation of the immunohistochemical characters and functional features of TCs so as to lay the foundation for the acquirement of specific TEM diagnostic results in reconstituted tissues. Assembly into specific structure was the basis of cytological behaviours of cancer cells. TCs seemed to play a potential role in manipulating the biological properties of breast cancer. The current study suggested that TCs and other stromal cells in the reconstituted breast cancer tissue might promote the growth of cancer cells and help them resistant to apoptosis. As there are some lines of evidence regarding the intercellular communication functions of TCs through transmission of multi-vesicular bodies to deliver the signal molecules [4, 44] and through gap junctions [1, 45], this kind of communication might still exist in the self-assembled breast cancer tissues, which might contribute cancer cells adaptive to tumour microenvironment including hypoxia, low pH and acidosis. Considering the spatial relationship between TCs and cancer cells that we observed in the study, TCs might be involved in the programming of potentiating cell growth and against apoptosis of breast cancer. In conclusion, TCs with long, thin prolongations were detected and connected with other stromal cells to form a complex interstitial network in 2D cultured breast stromal cells. In EMT-6/stromal cells reconstituted breast cancer tissue in vitro, TCs survived and accompanied by cancer cells to exert potential functions, such as assisting the self-assembly of cells, inhibition of apoptosis, facilitating growth of cancer cells. Exploration of the potential function of TCs would be helpful to understand the mechanism of breast cancer assembly and find possible therapeutic strategies targeting tumour stromal microenvironment.
  45 in total

1.  Cajal-type cells from human mammary gland stroma: phenotype characteristics in cell culture.

Authors:  E Radu; T Regalia; Laura Ceafalan; F Andrei; D Cretoiu; L M Popescu
Journal:  J Cell Mol Med       Date:  2005 Jul-Sep       Impact factor: 5.310

2.  A role for the TGFbeta-Par6 polarity pathway in breast cancer progression.

Authors:  Alicia M Viloria-Petit; Laurent David; Jun Yong Jia; Tuba Erdemir; Anita L Bane; Dushanthi Pinnaduwage; Luba Roncari; Masahiro Narimatsu; Rohit Bose; Jason Moffat; John W Wong; Robert S Kerbel; Frances P O'Malley; Irene L Andrulis; Jeffrey L Wrana
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-10       Impact factor: 11.205

3.  Co-culture of primary human mammary fibroblasts and MCF-7 cells as an in vitro breast cancer model.

Authors:  Marjoke Heneweer; Martine Muusse; Milou Dingemans; Paul C de Jong; Martin van den Berg; J Thomas Sanderson
Journal:  Toxicol Sci       Date:  2004-11-03       Impact factor: 4.849

4.  Telocytes in human term placenta: morphology and phenotype.

Authors:  Laura Suciu; Laurenţiu M Popescu; Mihaela Gherghiceanu; Teodor Regalia; Mihnea I Nicolescu; Mihail E Hinescu; Maria-Simonetta Faussone-Pellegrini
Journal:  Cells Tissues Organs       Date:  2010-07-27       Impact factor: 2.481

5.  Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization.

Authors:  Massimiliano Mazzone; Daniela Dettori; Rodrigo Leite de Oliveira; Sonja Loges; Thomas Schmidt; Bart Jonckx; Ya-Min Tian; Anthony A Lanahan; Patrick Pollard; Carmen Ruiz de Almodovar; Frederik De Smet; Stefan Vinckier; Julián Aragonés; Koen Debackere; Aernout Luttun; Sabine Wyns; Benedicte Jordan; Alberto Pisacane; Bernard Gallez; Maria Grazia Lampugnani; Elisabetta Dejana; Michael Simons; Peter Ratcliffe; Patrick Maxwell; Peter Carmeliet
Journal:  Cell       Date:  2009-02-12       Impact factor: 41.582

6.  Molecular predictors of 3D morphogenesis by breast cancer cell lines in 3D culture.

Authors:  Ju Han; Hang Chang; Orsi Giricz; Genee Y Lee; Frederick L Baehner; Joe W Gray; Mina J Bissell; Paraic A Kenny; Bahram Parvin
Journal:  PLoS Comput Biol       Date:  2010-02-26       Impact factor: 4.475

7.  Characterization of primary breast carcinomas grown in three-dimensional cultures.

Authors:  Jeanne L Becker; D Kay Blanchard
Journal:  J Surg Res       Date:  2007-08-29       Impact factor: 2.192

8.  Telocytes and putative stem cells in the lungs: electron microscopy, electron tomography and laser scanning microscopy.

Authors:  Laurentiu M Popescu; Mihaela Gherghiceanu; Laura C Suciu; Catalin G Manole; Mihail E Hinescu
Journal:  Cell Tissue Res       Date:  2011-08-20       Impact factor: 5.249

9.  Endothelial induced EMT in breast epithelial cells with stem cell properties.

Authors:  Valgardur Sigurdsson; Bylgja Hilmarsdottir; Hekla Sigmundsdottir; Agla J R Fridriksdottir; Markus Ringnér; Rene Villadsen; Ake Borg; Bjarni A Agnarsson; Ole William Petersen; Magnus K Magnusson; Thorarinn Gudjonsson
Journal:  PLoS One       Date:  2011-09-06       Impact factor: 3.240

10.  Cancer cell migration: integrated roles of matrix mechanics and transforming potential.

Authors:  Erin L Baker; Jaya Srivastava; Dihua Yu; Roger T Bonnecaze; Muhammad H Zaman
Journal:  PLoS One       Date:  2011-05-27       Impact factor: 3.240

View more
  30 in total

1.  Cardiac telocytes are double positive for CD34/PDGFR-α.

Authors:  Qiulian Zhou; Lei Wei; Chongjun Zhong; Siyi Fu; Yihua Bei; Radu-Ionuț Huică; Fei Wang; Junjie Xiao
Journal:  J Cell Mol Med       Date:  2015-06-17       Impact factor: 5.310

Review 2.  Intercellular Signaling in Cancer-the SMT and TOFT Hypotheses, Exosomes, Telocytes and Metastases: Is the Messenger in the Message?

Authors:  John Smythies
Journal:  J Cancer       Date:  2015-05-23       Impact factor: 4.207

3.  Exosomal transfer of vasorin expressed in hepatocellular carcinoma cells promotes migration of human umbilical vein endothelial cells.

Authors:  Aixue Huang; Jie Dong; Shaohua Li; Chaonan Wang; Hongmei Ding; Hui Li; Xueting Su; Xingfeng Ge; Leqiao Sun; Chenjun Bai; Xuelian Shen; Tao Fang; Jie Li; Ningsheng Shao
Journal:  Int J Biol Sci       Date:  2015-06-11       Impact factor: 6.580

4.  In vitro morphology, viability and cytokine secretion of uterine telocyte-activated mouse peritoneal macrophages.

Authors:  Chi Chi; Xiao-Juan Jiang; Lei Su; Zong-Ji Shen; Xiao-Jun Yang
Journal:  J Cell Mol Med       Date:  2015-10-16       Impact factor: 5.310

5.  Telocytes in Crohn's disease.

Authors:  Anna Franca Milia; Martina Ruffo; Mirko Manetti; Irene Rosa; Dalila Conte; Marilena Fazi; Luca Messerini; Lidia Ibba-Manneschi
Journal:  J Cell Mol Med       Date:  2013-11-19       Impact factor: 5.310

6.  Protein profiling of human lung telocytes and microvascular endothelial cells using iTRAQ quantitative proteomics.

Authors:  Yonghua Zheng; Dragos Cretoiu; Guoquan Yan; Sanda Maria Cretoiu; Laurentiu M Popescu; Hao Fang; Xiangdong Wang
Journal:  J Cell Mol Med       Date:  2014-06       Impact factor: 5.310

Review 7.  Telocytes in regenerative medicine.

Authors:  Yihua Bei; Fei Wang; Changqing Yang; Junjie Xiao
Journal:  J Cell Mol Med       Date:  2015-06-08       Impact factor: 5.310

8.  Telocytes: novel interstitial cells present in the testis parenchyma of the Chinese soft-shelled turtle Pelodiscus sinensis.

Authors:  Ping Yang; Nisar Ahmad; Yufei Hunag; Shakeeb Ullah; Qian Zhang; Yasir Waqas; Yi Liu; Quanfu Li; Lisi Hu; Qiusheng Chen
Journal:  J Cell Mol Med       Date:  2015-12       Impact factor: 5.310

9.  Global comparison of chromosome X genes of pulmonary telocytes with mesenchymal stem cells, fibroblasts, alveolar type II cells, airway epithelial cells, and lymphocytes.

Authors:  Yichun Zhu; Minghuan Zheng; Dongli Song; Ling Ye; Xiangdong Wang
Journal:  J Transl Med       Date:  2015-09-28       Impact factor: 5.531

10.  Telocytes in liver: electron microscopic and immunofluorescent evidence.

Authors:  Junjie Xiao; Fei Wang; Zhenguo Liu; Changqing Yang
Journal:  J Cell Mol Med       Date:  2013-11-25       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.